Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granix vs Neupogen for Stem Cell Mobilization in Multiple Myeloma or Non-Hodgkin Lymphoma
NCT02098109Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2014
- Primary completion
- Jun 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of tbo-filgrastim in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), sponsored by Washington University School of Medicine. Started Aug 2014; status: completed.
02
Drugs
tbo-filgrastim
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02098109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098109.